Contrast Media Injectors Market Thumbnail Image

2021

Contrast Media Injectors Market

Contrast Media Injectors Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, Application and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

LS : Healthcare

Select an option
Author's: Apoorva Srivastava | Roshan Deshmukh
Publish Date:

Get Sample to Email

Contrast Media Injectors Market Overview:

The global contrast media injectors market size was valued at $1,405.90 million in 2020, and is estimated to reach $2,608.20 million by 2030, growing at a CAGR of 8.00% from 2021 to 2030.

Contrast media injectors are instruments used to control contrast material prior to diagnostic imaging techniques, such as CT or MRI scans, to increase the image quality. Contrast media injectors include features, such as preset protocols and safety mechanisms, to avoid extravasation of contrast media by physicians. Counter media injectors may lessen the risk of undesirable consequences, such as the formation of air emboli, caused by inappropriate contrast material injection. As they minimize the volume of contrast view, the contrast of the injectors is substantially increased.

Contrast-Media-Injectors-Market-2021-2030

The COVID-19 pandemic has a severe global impact on population health as well as a significant economic impact on majority of countries. The pandemic has put enormous strain on the world's healthcare systems. During this time, health care institutions and providers have been told to avoid performing elective surgical procedures and medical examinations to slow disease spread and conserve health care resources for COVID-19 patients. Many radiology departments have witnessed a significant decrease in imaging case volume. Depending on the location of practice and the severity of the COVID-19 pandemic in each region, radiology offices should expect 50% to 70% decline in imaging volume that will persist for at least 3 to 4 months while the future appears to be uncertain due to COVID-19. The demand for contrast injectors will be primarily determined by the amount of diagnostic imaging and the number of CT and MRI installations. We may expect diagnostic imaging demand to return to normalcy in a few months, which may also lead to a recovery in demand for contrast injectors.

Factors, such as the rising prevalence of cancer and CVD, a significant number of contrast agent approvals, and increased investments, funding, & grants from government organizations, are propelling the contrast media injectors market growth. However, the high cost of contrast media injectors and consumables and accessories is limiting the market expansion to some extent.

Contrast Media Injectors Market Segmentation

The contrast media injectors market is segmented on the basis of product type, application, end-user, and region. By product type, the market is categorized into consumables, injector systems, and accessories. By application, it is fragmented into radiology, interventional cardiology, and interventional radiology. By end user, it is segregated into hospitals, ambulatory surgery centers, and diagnostics imaging centers.

Contrast Media Injectors Market
By Product Product
Your browser does not support the canvas element.

Consumables segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.

Region-wise, the contrast media injectors market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Contrast Media Injectors Market
By Application
Your browser does not support the canvas element.

Radiology segment is projected as one of the most lucrative segments.

Segment review

On the basis of product type, the consumables segment is expected to witness the highest growth rate during the forecast period. The high growth rate in this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures. On the basis of application, the radiology segment will continue to dominate the applications segment of the contrast media injector market during the forecast period. This is attributed to the rising number of radiology procedures using contrast media.

Contrast Media Injectors Market
By End User
Your browser does not support the canvas element.

Hospitals segment holds the dominant position in 2020 and would continue to maintain the lead over the forecast period.

North America accounted for a major share in the contrast media injectors market in 2020, and is expected to maintain its dominance during the forecast period, owing to well-established healthcare infrastructure. Furthermore, factors, such as growing preference for minimally invasive procedures and an increase in the prevalence of chronic diseases as a result of changing lifestyles, propel the market growth. The Asia Pacific market, on the other hand, is predicted to grow at the fastest CAGR during the forecast period, owing to factors such as increased R&D investments, favorable demographic scenario in China, aging population, and cancer incidences in Japan. There is growing investment in the India radiology market as well as increased attention of market participants and government support to boost healthcare service delivery in Asia-Pacific.

Contrast Media Injectors Market
By Region
2030
North America 
Europe
Asia-Pacific
LAMEA

Asia-Pacific region would exhibit the highest CAGR of 9.6% during 2021-2030

The key players operating in the global contrast media injectors market include Bayer HealthCare LLC; Bracco Imaging S.P.A, Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd., APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., and Medtron AG.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the contrast media injectors market and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the contrast media injectors market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the contrast media injectors market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the contrast media injectors market.

Key Market Segments

By Product Type

  • Consumables
    • Syringes
    • Tubes
    • Other Consumables
  • Injector Systems
    • CT Injectors
    • MRI Injectors
    • Angiography Injectors
    • Accessories

By Application 

  • Radiology
  • Interventional Cardiology
  • Interventional Radiology

By End User 

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostics Imaging Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

KEY MARKET PLAYERS 

  • Bayer Ag
  • Bracco Imaging S.P.A 
  • Guerbet Group
  • Ulrich GmbH & Co. KG
  • Nemoto Kyorindo Co., Ltd
  • Sino Medical-Device Technology Co., Ltd.
  • APOLLO RT Co. Ltd. 
  • Shenzhen Anke High-tech Co. Ltd 
  • Shenzen Seacrown Electromechanical Co Ltd. 
  • Medtron AG RT Co. Ltd.

Contrast Media Injectors Market Report Highlights

Aspects Details
icon_5
By Product Type
  • Consumables
    • Syringes
    • Tubes
    • Other Consumables
  • Injector Systems
    • CT Injectors
    • MRI Injectors
    • Angiography Injectors
    • Accessories
icon_6
By Application
  • Radiology
  • Interventional Cardiology
  • Interventional Radiology
icon_7
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostics Imaging Centers
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_9
Key Market Players

ULRICH GmbH & CO. KG, MEDTRON AG, THE GUERBET GROUP, NEMOTO KYORINDO CO., LTD., BAYER AG, SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD., APOLLO RT CO. LTD., BRACCO S.P.A., SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD., SHENZHEN ANKE HIGH-TECH CO., LTD.

Analyst Review

The contrast media injectors market gained prominence in 2020, and is expected to witness significant rise in the near future. This is attributed to the growing prevalence of cancer and cardiovascular diseases. As per the World Cancer Report, 2003 by WHO, the number of people suffering from cancer is expected to increase by 50% to 15 million by 2020. Likewise, CVDs and strokes are the leading causes of death around the world. WHO estimated that in 2015, approximately 17.7 million people died of CVDs, which represented 31% of the global deaths and the number is estimated to increase to 23.6 million by 2030.

A large number of approvals for contrast agents and increasing investments, funds, & grants by government organizations are driving the growth of the contrast media injectors market. However, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market to a certain extent.

Other key factors expected to drive the market growth are technological advancements in contrast media injector devices and increasing expenditure by key players along with rising regulatory approvals.
 

Author Name(s) : Apoorva Srivastava | Roshan Deshmukh
Frequently Asked Questions?

Contrast delivery is also known as a power injector which is the most effective therapeutic device that can be programmed to deliver specific measures of contrast agent at particular flow rates.

The total market value of contrast media injectors marketis $1,405.90 million in 2020.

The market value of contrast media injectors market in 2030 is $2,608.20 million.

The base year is 2020 in mental health market

Top companies such as, Bayer Ag, Bracco Imaging S.P.A, Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

In product type, consumables segment depression is the most influencing segment. The high growth rate in this segment can be attributed to the growing requirement of consumables to maintain safety and hygienic conditions during diagnostic procedures.

The major factor that fuels the growth of the global contrast media injectors market includes, increasing prevalence of cancer and cardiovascular diseases, artificial intelligence to provide faster results, increasing demand for MRI scans and increase in unhealthy lifestyle drive the growth of the global contrast media injectors market. However, high cost of contrast media injectors, consumables and accessories is expected to hamper the market growth.

Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the emerging countries.This attributed to increase in health awareness, development in healthcare infrastructure, and rise in number of hospitals equipped with advanced medical facilities

The forcast period for contrast media injectors market is 2021 to 2030

radiology, interventional cardiology, and interventional radiology

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Contrast Media Injectors Market

Global Opportunity Analysis and Industry Forecast, 2021-2030